Article
Safety and Tolerability of OncoRob © in Patients with Advanced Malignant Solid Tumors under Compassionate Use.
2025-10-07
Abstract excerpt
<title>Abstract</title> <p> <italic>Relevance:</italic> <bold/> OncoRob is a fourth generation bacteriophage-based, highly selective oncolytic Bio-Robot for intravenous systemic administration in cancer patients. It can target, destroy cancer cells and avoid innate and adaptive immune response. In addition, it can distinguish between early and late stage cancer. <italic>Purpose:</italic> <bold/> Firstly, to...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 52a63810-804f-5f57-a0b9-58d763728e06
- DOI
- 10.21203/rs.3.rs-7783396/v1
